Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 12Carcinoid Tumor 7Somatostatinoma 4Neoplasms 4Insulinoma 4Glucagonoma 4Gastro-enteropancreatic neuroendocrine tumor 4Carcinoma, Islet Cell 4Vipoma 3Gastrinoma 3Adenoma, Islet Cell 3Acromegaly 3Pituitary Neoplasms 2Neoplasm Metastasis 2Carcinoma, Medullary 2Carcinoma 2Zollinger-Ellison Syndrome 1Serotonin Syndrome 1Pheochromocytoma 1Paraganglioma 1Pancreatic Neuroendocrine Tumor G2 1Neoplastic Cells, Circulating 1Malignant Carcinoid Syndrome 1Head and Neck Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3entrectinib 2Radiotherapy 2Proton Therapy 2Fluorodeoxyglucose F18 2FAPI-46 2tipifarnib 1pegvisomant 1fluorodopa F 18 1entinostat 1dactolisib 1alectinib 1Trastuzumab 1Tamoxifen 1Surveys and Questionnaires 1Specimen Handling 1Ritonavir 1Respiratory Therapy 1Radiation Dose Hypofractionation 1Quality of Life 1Protons 1Positron-Emission Tomography 1Photochemotherapy 1Patient Reported Outcome Measures 1Octreotide 1Neuropsychological Tests 1Molecular Diagnostic Techniques 1Indinavir 1Immunotherapy 1Furosemide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Octreotide × Endocrine × Clear all
NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed
20 enrolled
CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡